Literature DB >> 25982971

Predominantly Cone-System Dysfunction as Rare Form of Retinal Degeneration in Patients With Molecularly Confirmed Bardet-Biedl Syndrome.

Sophie Scheidecker1, Sarah Hull2, Yaumara Perdomo1, Fouzia Studer1, Valérie Pelletier1, Jean Muller3, Corinne Stoetzel4, Elise Schaefer1, Sabine Defoort-Dhellemmes5, Isabelle Drumare5, Graham E Holder6, Christian P Hamel7, Andrew R Webster2, Anthony T Moore8, Bernard Puech5, Hélène J Dollfus9.   

Abstract

PURPOSE: To describe a series of patients with Bardet-Biedl syndrome (BBS) and predominantly retinal cone dysfunction, a previously only rarely reported association.
DESIGN: Retrospective observational case series.
METHODS: Seven patients with clinically proven Bardet-Biedl syndrome had undergone detailed ocular phenotyping, which included fundus examination, Goldmann visual fields, fundus autofluorescence imaging (FAF), optical coherence tomography (OCT), and electroretinography (ERG). Mutational screening in the BBS genes was performed either by direct Sanger sequencing or targeted next-generation sequencing.
RESULTS: All 7 patients had proven BBS mutations; 1 had a cone dystrophy phenotype on ERG and 6 had a cone-rod pattern of dysfunction. Macular atrophy was present in all patients, usually with central hypofluorescence surrounded by a continuous hyperfluorescent ring on fundus autofluorescence imaging. OCT confirmed loss of outer retinal structure within the atrophic areas. No clear genotype-phenotype relationship was evident.
CONCLUSIONS: Patients with Bardet-Biedl syndrome usually develop early-onset retinitis pigmentosa. In contrast, the patients described herein, with molecularly confirmed Bardet-Biedl syndrome, developed early cone dysfunction, including the first reported case of a cone dystrophy phenotype associated with the disorder. The findings significantly expand the phenotype associated with Bardet-Biedl syndrome.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25982971     DOI: 10.1016/j.ajo.2015.05.007

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  9 in total

1.  Bardet-Biedl syndrome-8 (BBS8) protein is crucial for the development of outer segments in photoreceptor neurons.

Authors:  Tanya L Dilan; Ratnesh K Singh; Thamaraiselvi Saravanan; Abigail Moye; Andrew F X Goldberg; Peter Stoilov; Visvanathan Ramamurthy
Journal:  Hum Mol Genet       Date:  2018-01-15       Impact factor: 6.150

2.  Clinical characteristics of a Japanese patient with Bardet-Biedl syndrome caused by BBS10 mutations.

Authors:  Kentaro Kurata; Katsuhiro Hosono; Akiko Hikoya; Akihiko Kato; Hirotomo Saitsu; Shinsei Minoshima; Tsutomu Ogata; Yoshihiro Hotta
Journal:  Jpn J Ophthalmol       Date:  2018-04-17       Impact factor: 2.447

3.  Genotype and Phenotype in an unusual form of Laurence-Moon-Bardet-Biedl syndrome.

Authors:  Christina Kamme; Anja Kathrin Mayer; Tim M Strom; Sten Andréasson; Nicole Weisschuh
Journal:  Acta Ophthalmol       Date:  2016-11-23       Impact factor: 3.761

4.  Novel splicing variant c. 208+2T>C in BBS5 segregates with Bardet-Biedl syndrome in an Iranian family by targeted exome sequencing.

Authors:  Saber Imani; Jingliang Cheng; Jiewen Fu; Abdolkarim Mobasher-Jannat; Chunli Wei; Saman Mohazzab-Torabi; Khosrow Jadidi; Mohammad Hossein Khosravi; Marzieh Dehghan Shasaltaneh; Lisha Yang; Md Asaduzzaman Khan; Junjiang Fu
Journal:  Biosci Rep       Date:  2019-03-28       Impact factor: 3.840

Review 5.  Genetics behind Cerebral Disease with Ocular Comorbidity: Finding Parallels between the Brain and Eye Molecular Pathology.

Authors:  Kao-Jung Chang; Hsin-Yu Wu; Aliaksandr A Yarmishyn; Cheng-Yi Li; Yu-Jer Hsiao; Yi-Chun Chi; Tzu-Chen Lo; He-Jhen Dai; Yi-Chiang Yang; Ding-Hao Liu; De-Kuang Hwang; Shih-Jen Chen; Chih-Chien Hsu; Chung-Lan Kao
Journal:  Int J Mol Sci       Date:  2022-08-26       Impact factor: 6.208

Review 6.  Monitoring and Management of Bardet-Biedl Syndrome: What the Multi-Disciplinary Team Can Do.

Authors:  Lavinia Caba; Laura Florea; Elena Emanuela Braha; Valeriu Vasile Lupu; Eusebiu Vlad Gorduza
Journal:  J Multidiscip Healthc       Date:  2022-09-27

7.  Bardet-Biedl syndrome-7 (BBS7) shows treatment potential and a cone-rod dystrophy phenotype that recapitulates the non-human primate model.

Authors:  Tomas S Aleman; Erin C O'Neil; Keli O'Connor; Yu You Jiang; Isabella A Aleman; Jean Bennett; Jessica I W Morgan; Brian W Toussaint
Journal:  Ophthalmic Genet       Date:  2021-03-17       Impact factor: 1.274

8.  BBSome Component BBS5 Is Required for Cone Photoreceptor Protein Trafficking and Outer Segment Maintenance.

Authors:  Katie L Bales; Melissa R Bentley; Mandy J Croyle; Robert A Kesterson; Bradley K Yoder; Alecia K Gross
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-08-03       Impact factor: 4.799

9.  Comparative Natural History of Visual Function From Patients With Biallelic Variants in BBS1 and BBS10.

Authors:  Monika K Grudzinska Pechhacker; Samuel G Jacobson; Arlene V Drack; Matteo Di Scipio; Ine Strubbe; Wanda Pfeifer; Jacque L Duncan; Helene Dollfus; Nathalie Goetz; Jean Muller; Andrea L Vincent; Tomas S Aleman; Anupreet Tumber; Caroline Van Cauwenbergh; Elfride De Baere; Emma Bedoukian; Bart P Leroy; Jason T Maynes; Francis L Munier; Erika Tavares; Eman Saleh; Ajoy Vincent; Elise Heon
Journal:  Invest Ophthalmol Vis Sci       Date:  2021-12-01       Impact factor: 4.799

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.